NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
QTTB Q32 Bio
- 3.590
- +0.250+7.49%
Close Dec 20 16:00 ET
- 3.610
- +0.020+0.56%
Post 20:01 ET
43.73MMarket Cap-0.27P/E (TTM)
3.770High3.140Low845.96KVolume3.300Open3.340Pre Close2.99MTurnover16.61%Turnover RatioLossP/E (Static)12.18MShares53.79052wk High2.39P/B18.29MFloat Cap3.02052wk Low--Dividend TTM5.09MShs Float546.837Historical High--Div YieldTTM18.86%Amplitude3.020Historical Low3.529Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Q32 Bio Stock Forum
Worse than placebo for Eczema, ouch
Alopecia worked well, but probably people were looking for the eczema market?
Sorry I am sleepy cant finish the list.
$Rigetti Computing (RGTI.US)$ PR today 12/10: Quantum Machines And Rigetti Computing Announces The Application Of AI To Automate The Calibration Of A Quantum Computer. Up after hours. SI 13.89%, 0 shares LTB✅
$SEALSQ Corp (LAES.US)$ PR 12/10: Partnership with IC’ALPS to ...
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Tuesday, 10th December at 4:05 pm
-- SIGNAL-AA demonstrated encouraging clinical activity of bempikibart in patients with alopecia areata (AA), including improvement from baseline on SALT score and meaningful achievement of SALT-20 response --
-- SIGNAL-AD Phase 2a clinical trial in atopic dermatitis demonstrated promising findings in Part A but did not meet ...
$Trio Petroleum (TPET.US)$ buy
No comment yet